CN101291599A - 对骨骼肌供给能量和保护心血管的膳食补充剂 - Google Patents

对骨骼肌供给能量和保护心血管的膳食补充剂 Download PDF

Info

Publication number
CN101291599A
CN101291599A CNA2006800388186A CN200680038818A CN101291599A CN 101291599 A CN101291599 A CN 101291599A CN A2006800388186 A CNA2006800388186 A CN A2006800388186A CN 200680038818 A CN200680038818 A CN 200680038818A CN 101291599 A CN101291599 A CN 101291599A
Authority
CN
China
Prior art keywords
carnitine
acid
milligrams
dietary supplements
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800388186A
Other languages
English (en)
Chinese (zh)
Inventor
F·加埃塔尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN101291599A publication Critical patent/CN101291599A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2006800388186A 2005-10-20 2006-09-20 对骨骼肌供给能量和保护心血管的膳食补充剂 Pending CN101291599A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/253,806 2005-10-20
US11/253,806 US8252309B2 (en) 2000-04-04 2005-10-20 Dietary supplement energy-providing to skeletal muscles

Publications (1)

Publication Number Publication Date
CN101291599A true CN101291599A (zh) 2008-10-22

Family

ID=37479888

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800388186A Pending CN101291599A (zh) 2005-10-20 2006-09-20 对骨骼肌供给能量和保护心血管的膳食补充剂

Country Status (19)

Country Link
US (2) US8252309B2 (enExample)
EP (1) EP1940251B1 (enExample)
JP (1) JP2009512430A (enExample)
CN (1) CN101291599A (enExample)
AR (1) AR056129A1 (enExample)
AT (1) ATE535159T1 (enExample)
AU (1) AU2006303417A1 (enExample)
BR (1) BRPI0617487A2 (enExample)
CA (1) CA2622555A1 (enExample)
CY (1) CY1112660T1 (enExample)
DK (1) DK1940251T3 (enExample)
ES (1) ES2378655T3 (enExample)
HR (1) HRP20120138T1 (enExample)
PL (1) PL1940251T3 (enExample)
PT (1) PT1940251E (enExample)
RS (1) RS52129B (enExample)
SI (1) SI1940251T1 (enExample)
TW (1) TW200803761A (enExample)
WO (1) WO2007045533A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112535294A (zh) * 2020-11-24 2021-03-23 苏州麦轮生物科技有限公司 牛磺酸镁在制备改善心血管健康的营养补充剂中的应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070091A1 (en) * 2002-02-22 2003-08-28 Hans Gregersen Method and apparatus for investigating force-deformation properties in muscles in walls of bodily hollow systems
IN2013MN01582A (enExample) 2011-01-20 2015-06-12 Oneday Biotech And Pharma Ltd
JP2014131961A (ja) * 2011-04-08 2014-07-17 Mitsubishi Gas Chemical Co Inc 動物用栄養組成物
CN104717970A (zh) 2012-07-23 2015-06-17 万德-生物技术及制药有限公司 提高谷胱甘肽的组合物及其用途
EP2877194A4 (en) 2012-07-25 2016-03-16 Oneday Biotech And Pharma Ltd Compositions and methods for increasing carnitine concentration in muscle tissue
US9327005B1 (en) 2012-11-15 2016-05-03 Vdf Futureceuticals, Inc. Compositions and methods for improved energy metabolism
KR101636946B1 (ko) * 2013-07-29 2016-07-06 한국생명공학연구원 오로트산을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
AU2019261476B2 (en) * 2018-04-25 2021-11-18 Oncocross Co.,Ltd. Composition for preventing and treating muscular disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219454A (en) 1961-06-15 1965-11-23 Borden Co Low calorie diet
US3689641A (en) 1970-08-20 1972-09-05 Merck & Co Inc Concentrated water suspension of nutrients
US4237118A (en) 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
US5466469A (en) * 1988-06-28 1995-11-14 Cibus Pharmaceutical, Inc. Granular drug delivery system
DE4410238A1 (de) 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
IT1275434B (it) 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1277953B1 (it) 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IL127266A (en) * 1996-05-31 2002-09-12 Sigma Tau Ind Farmaceuti Stable, non-hygroscopic mucate salts of l(-) carnitine and alkanoyl l(-) carnitines, a process for their preparation and solid, orally administrable compositions containing such salts
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1299161B1 (it) 1998-04-17 2000-02-29 Sigma Tau Healthscience Spa Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
US6479069B1 (en) * 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
WO2002047493A2 (en) * 2000-12-16 2002-06-20 Aventis Pharma Deutschland Gmbh Health promoting compositions
JP2004081010A (ja) * 2002-08-22 2004-03-18 Fancl Corp 食品組成物
JP2005097161A (ja) * 2003-09-24 2005-04-14 Nisshin Pharma Inc 抗疲労用組成物およびこれを含有する食品
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
WO2005060952A1 (en) * 2003-12-24 2005-07-07 N.V. Nutricia Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112535294A (zh) * 2020-11-24 2021-03-23 苏州麦轮生物科技有限公司 牛磺酸镁在制备改善心血管健康的营养补充剂中的应用

Also Published As

Publication number Publication date
TW200803761A (en) 2008-01-16
EP1940251A1 (en) 2008-07-09
ATE535159T1 (de) 2011-12-15
WO2007045533A1 (en) 2007-04-26
CA2622555A1 (en) 2007-04-26
HRP20120138T1 (hr) 2012-05-31
US20060057188A1 (en) 2006-03-16
EP1940251B1 (en) 2011-11-30
ES2378655T3 (es) 2012-04-16
SI1940251T1 (sl) 2012-03-30
AU2006303417A1 (en) 2007-04-26
US20090257996A1 (en) 2009-10-15
RS52129B (sr) 2012-08-31
JP2009512430A (ja) 2009-03-26
BRPI0617487A2 (pt) 2011-07-26
CY1112660T1 (el) 2016-02-10
PL1940251T3 (pl) 2012-05-31
US8252309B2 (en) 2012-08-28
DK1940251T3 (da) 2012-03-19
AR056129A1 (es) 2007-09-19
PT1940251E (pt) 2012-03-16

Similar Documents

Publication Publication Date Title
CN101291599A (zh) 对骨骼肌供给能量和保护心血管的膳食补充剂
JPH07509230A (ja) クレアチン供給デポーの増加法
JP7738384B2 (ja) 持久運動能力を向上させるためおよび脂質代謝を刺激するためのコラーゲン加水分解物の使用
Paul et al. Amino acid and protein metabolism during exercise and recovery
HUP0202298A2 (en) Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise
CA2374333C (en) Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
AU782367B2 (en) Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
CN101331950B (zh) 一种提高运动爆发力的营养补剂
CN112384215A (zh) 通过d-核糖和维生素b3提高哺乳动物中nad含量的方法及成分
Figueiredo et al. Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi
HK1125268A (en) Dietary supplemant energy-providing to skeletal muscles and protecting the cardio vascular tract
Ööpik et al. Effect of creatine administration on blood urea level and postexercise glycogen repletion in liver and skeletal muscle in rats
Semanchik et al. Influence of Mechanistic Target of Rapamycin (mTOR)-Regulated Anabolic Pathways on Equine Skeletal Muscle Health
Hoffman Creatine and β-alanine supplementation in strength/power athletes.
Kostadinova et al. Creatine lysinate–part I: investigation of the toxicity and the influence on some biochemical parameters in mice
Kostadinova et al. Creatine lysinate–part I: investigation of the toxicity and the influence on some biochemical parameters in mice. Pharmacia 70 (4): 895–899
Smith Metabolism of muscle at rest and during exercise
TRAPPE 18 METABOLIC DEMANDS FOR SWIMMING
Vargiu et al. 1Department of Science Applied to Biosystems, Section of Physiology and Human Nutrition, University of Cagliari, Italy 2Department of Biochemistry, Biology and Genetics, Marche Polytechnic University, Ancona, Italy 3Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy
CZ347999A3 (cs) Doplňková výživa pro snazší adaptaci kosterního svalstva vyčerpaného zatěžujícími výkony a paralyzování únavy asthenických jedinců

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1125268

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081022

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1125268

Country of ref document: HK